Brazil, where the obesity rate has surged over the past decade, is now the biggest growth driver for weight-loss treatments in the world and the No. 2 market for Saxenda, Novo Nordisk A/S’s industry-leading drug.
from Hindustan Times - world https://ift.tt/2Ok2shY
No comments:
Post a Comment